Edap Tms (NASDAQ:EDAP) Coverage Initiated at StockNews.com

Research analysts at StockNews.com began coverage on shares of Edap Tms (NASDAQ:EDAP) in a report released on Saturday. The brokerage set a “hold” rating on the medical equipment provider’s stock.

Other equities research analysts have also issued research reports about the stock. Piper Sandler reduced their price objective on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research note on Friday, March 28th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $2.00 price target (down previously from $8.00) on shares of Edap Tms in a research report on Friday. Finally, HC Wainwright reissued a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a report on Friday, March 28th.

Edap Tms Stock Performance

Shares of NASDAQ EDAP opened at $1.61 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms has a one year low of $1.51 and a one year high of $8.50. The business’s 50-day moving average price is $2.39 and its two-hundred day moving average price is $2.45. The company has a market capitalization of $59.74 million, a P/E ratio of -2.48 and a beta of 0.37.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.06. The business had revenue of $22.69 million during the quarter, compared to analysts’ expectations of $20.83 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. Analysts anticipate that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Edap Tms

A number of hedge funds have recently bought and sold shares of the company. Rock Springs Capital Management LP lifted its position in shares of Edap Tms by 1.5% during the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock worth $3,518,000 after purchasing an additional 23,800 shares during the last quarter. Schonfeld Strategic Advisors LLC lifted its holdings in shares of Edap Tms by 48.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock worth $355,000 after buying an additional 52,500 shares during the last quarter. Orion Capital Management LLC boosted its position in shares of Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after acquiring an additional 6,600 shares during the period. Millennium Management LLC grew its stake in shares of Edap Tms by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 33,558 shares during the last quarter. Finally, BNP Paribas Financial Markets increased its position in Edap Tms by 111.5% during the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 25,650 shares during the period. 62.74% of the stock is currently owned by institutional investors.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.